NCT02972853

Brief Summary

The purpose of this study is to 1) determine whether Mindfulness Training for Primary Care (see study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study") engages self-regulation targets such as emotion regulation, attention, and interoceptive awareness; and 2) changes brain activation in neuroimaging tasks before compared to after the training. Neuroimaging fMRI tasks probe mechanisms related to self-regulation, such as attention/inhibition, emotion regulation, self-compassion, interoception and pain regulation. The study will also look at whether chronic disease self-management and successful engagement of self-report and behavioral self-regulation targets (emotion regulation, attention, and interoceptive awareness) relates to the observed brain activation changes after compared to before the mindfulness intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 25, 2016

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

October 21, 2021

Status Verified

October 1, 2021

Enrollment Period

3.8 years

First QC Date

November 16, 2016

Last Update Submit

October 20, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Brain activation in regions of interest

    Change in brain activation will be measured with functional magnetic resonance imaging (fMRI) during four different tasks: an affective go/nogo regulation task, an interoceptive attention task, a self-compassion task and a pain regulation task. Brain activation will be compared between baseline and Week 8.

    8 weeks

Secondary Outcomes (2)

  • Correlations between brain activation changes and self-regulation measures

    8 weeks

  • Correlations between brain activation changes and chronic disease self-management action plan initiation.

    9 weeks

Study Arms (1)

Mindfulness Training for Primary Care

EXPERIMENTAL

For intervention description see Mindfulness Training for Primary Care (MTPC) in the study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study". For the Mindfulness Training for Primary Care (MTPC) fMRI - arm, we acquire pre-/post-intervention neuroimaging measures from subjects enrolled in this additional pilot fMRI study.

Behavioral: Mindfulness Training for Primary Care (MTPC)

Interventions

For intervention description see Mindfulness Training for Primary Care (MTPC) in the study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study"

Mindfulness Training for Primary Care

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults 21-60 years old enrolled for participation in the MINDFUL-PC study.
  • During baseline visit, patient has a history of either major depressive disorder, dysthymia, or generalized anxiety disorder, OR has current mild to moderate symptoms of depression (score range of 10-28 on DASS-21 Depression subscale) or anxiety (score \>7 on DASS-21 anxiety subscale).
  • Participant does not have a substance use disorder nor intoxication at the time of scanning. Participants must report no more than infrequent recreational cannabis use (i.e., no more than two times a month) and must report capacity for abstinence from both cannabis and ethyl alcohol for the 72 hours prior to the scan.
  • Normal or corrected-to-normal vision, and correction must be with contact lenses.
  • Right-handed as defined by Edinburgh Handedness Inventory.

You may not qualify if:

  • Current severe panic disorder, active severe PTSD symptoms, or psychosis.
  • Current suicidality OR severe depression as evidenced by a score of 28 or higher on the DASS-21 Depression subscale.
  • A history of neurological disease or injury, including a history of seizures or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion), or previous brain surgery.
  • Severe skin disease, skin allergies, or multiple reactions to topical preparations, dressings or tapes.
  • Current meditation or intense yoga practice or extensive previous experience.
  • Participants with vascular disease, such as peripheral vascular disease, varicose veins, or lymphedema, in both lower limbs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHA Center for Mindfulness and Compassion

Somerville, Massachusetts, 02143, United States

Location

MeSH Terms

Conditions

DepressionAnxiety DisordersSelf-Control

Interventions

Primary Health Care

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersSocial Behavior

Intervention Hierarchy (Ancestors)

Comprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Zev D Schuman-Olivier, MD

    Cambridge Health Alliance

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2016

First Posted

November 25, 2016

Study Start

September 1, 2016

Primary Completion

June 1, 2020

Study Completion

October 1, 2020

Last Updated

October 21, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations